BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chi OZ, Liu X, Cofano S, Patel N, Jacinto E, Weiss HR. Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption. Front Physiol 2021;12:706528. [PMID: 34354602 DOI: 10.3389/fphys.2021.706528] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Burek M, Kaupp V, Blecharz-lang K, Dilling C, Meybohm P. Protocadherin gamma C3: a new player in regulating vascular barrier function. Neural Regen Res 2023;18:68. [DOI: 10.4103/1673-5374.343896] [Reference Citation Analysis]
2 Selig JI, Krug HV, Küppers C, Ouwens DM, Kraft FA, Adler E, Bauer SJ, Lichtenberg A, Akhyari P, Barth M. Interactive contribution of hyperinsulinemia, hyperglycemia, and mammalian target of rapamycin signaling to valvular interstitial cell differentiation and matrix remodeling. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.942430] [Reference Citation Analysis]
3 Villa-gonzález M, Martín-lópez G, Pérez-álvarez MJ. Dysregulation of mTOR Signaling after Brain Ischemia. IJMS 2022;23:2814. [DOI: 10.3390/ijms23052814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu H, Qiu W, Sun T, Wang L, Du C, Hu Y, Liu W, Feng F, Chen Y, Sun H. Therapeutic strategies of glioblastoma (GBM): The current advances in the molecular targets and bioactive small molecule compounds. Acta Pharmaceutica Sinica B 2022;12:1781-804. [DOI: 10.1016/j.apsb.2021.12.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Beard DJ, Hadley G, Sutherland BA, Buchan AM. Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia-Reperfusion With Increased Blood-Brain Barrier Disruption. Front Physiol 2021;12:761556. [PMID: 34630168 DOI: 10.3389/fphys.2021.761556] [Reference Citation Analysis]